Request Sample Inquiry
Allergy Immunotherapy Market

Allergy Immunotherapy Market

Allergy Immunotherapy Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

130

Base Year:

2022

Date

Dec - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2360

Segments Covered
  • By Type By Type Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)
  • By Allergy Type By Allergy Type Allergic Rhinitis, Allergic Asthma, Food Allergy, Atopic Dermatitis, Other Allergy Types
  • By Distribution Channel By Distribution Channel Institutional Sales, Retail Sales
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1.63 Billion
Revenue 2030Revenue 2030: USD 3.33 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 9.2%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): Europe
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Allergy Immunotherapy Market - Segment Analysis
    1. Overview
    2. Global Allergy Immunotherapy Market, 2016 - 2028 (USD Million)
    3. Global Allergy Immunotherapy Market - by Type
      1. By Subcutaneous Immunotherapy (SCIT)
      2. By Sublingual Immunotherapy (SLIT)
    4. Global Allergy Immunotherapy Market - by Allergy Type
      1. By Allergic Rhinitis
      2. By Allergic Asthma
      3. By Food Allergy
      4. By Atopic Dermatitis
      5. By Other Allergy Types
    5. Global Allergy Immunotherapy Market - by Distribution Channel
      1. By Institutional Sales
      2. By Retail Sales
    6. Global Allergy Immunotherapy Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Allergy Immunotherapy Market - Segment Analysis
    1. Overview
    2. North America Allergy Immunotherapy Market, 2016 - 2028 (USD Million)
    3. North America Allergy Immunotherapy Market, by Type
      1. By Subcutaneous Immunotherapy (SCIT)
      2. By Sublingual Immunotherapy (SLIT)
    4. North America Allergy Immunotherapy Market, by Allergy Type
      1. By Allergic Rhinitis
      2. By Allergic Asthma
      3. By Food Allergy
      4. By Atopic Dermatitis
      5. By Other Allergy Types
    5. North America Allergy Immunotherapy Market, by Distribution Channel
      1. By Institutional Sales
      2. By Retail Sales
    6. North America Allergy Immunotherapy Market, by Country
      1. U.S.
        1. U.S. Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. U.S. Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. U.S. Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      2. Canada
        1. Canada Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Canada Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Canada Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      3. Mexico
        1. Mexico Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Mexico Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Mexico Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
  5. Europe Allergy Immunotherapy Market - Segment Analysis
    1. Overview
    2. Europe Allergy Immunotherapy Market, 2016 - 2028 (USD Million)
    3. Europe Allergy Immunotherapy Market, by Type
      1. By Subcutaneous Immunotherapy (SCIT)
      2. By Sublingual Immunotherapy (SLIT)
    4. Europe Allergy Immunotherapy Market, by Allergy Type
      1. By Allergic Rhinitis
      2. By Allergic Asthma
      3. By Food Allergy
      4. By Atopic Dermatitis
      5. By Other Allergy Types
    5. Europe Allergy Immunotherapy Market, by Distribution Channel
      1. By Institutional Sales
      2. By Retail Sales
    6. Europe Allergy Immunotherapy Market, by Country
      1. Germany
        1. Germany Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Germany Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Germany Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      2. UK
        1. UK Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. UK Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. UK Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      3. France
        1. France Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. France Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. France Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      4. Spain
        1. Spain Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Spain Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Spain Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      5. Italy
        1. Italy Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Italy Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Italy Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      6. BENELUX
        1. BENELUX Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. BENELUX Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. BENELUX Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      7. Rest of Europe
        1. Rest Of Europe Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Rest Of Europe Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Rest Of Europe Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
  6. Asia Pacific Allergy Immunotherapy Market - Segment Analysis
    1. Overview
    2. Asia Pacific Allergy Immunotherapy Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Allergy Immunotherapy Market, by Type
      1. By Subcutaneous Immunotherapy (SCIT)
      2. By Sublingual Immunotherapy (SLIT)
    4. Asia Pacific Allergy Immunotherapy Market, by Allergy Type
      1. By Allergic Rhinitis
      2. By Allergic Asthma
      3. By Food Allergy
      4. By Atopic Dermatitis
      5. By Other Allergy Types
    5. Asia Pacific Allergy Immunotherapy Market, by Distribution Channel
      1. By Institutional Sales
      2. By Retail Sales
    6. Asia Pacific Allergy Immunotherapy Market, by Country
      1. China
        1. China Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. China Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. China Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      2. Japan
        1. Japan Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Japan Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Japan Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      3. India
        1. India Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. India Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. India Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      4. South Korea
        1. South Korea Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. South Korea Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. South Korea Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      5. South East Asia
        1. South East Asia Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. South East Asia Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. South East Asia Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Rest of Asia Pacific Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Rest of Asia Pacific Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
  7. Latin America Allergy Immunotherapy Market - Segment Analysis
    1. Overview
    2. Latin America Allergy Immunotherapy Market, 2016 - 2028 (USD Million)
    3. Latin America Allergy Immunotherapy Market, by Type
      1. By Subcutaneous Immunotherapy (SCIT)
      2. By Sublingual Immunotherapy (SLIT)
    4. Latin America Allergy Immunotherapy Market, by Allergy Type
      1. By Allergic Rhinitis
      2. By Allergic Asthma
      3. By Food Allergy
      4. By Atopic Dermatitis
      5. By Other Allergy Types
    5. Latin America Allergy Immunotherapy Market, by Distribution Channel
      1. By Institutional Sales
      2. By Retail Sales
    6. Latin America Allergy Immunotherapy Market, by Country
      1. Brazil
        1. Brazil Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Brazil Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Brazil Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      2. Argentina
        1. Argentina Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Argentina Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Argentina Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      3. Rest of Latin America
        1. Rest of Latin America Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Rest of Latin America Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Rest of Latin America Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
  8. Middle East & Africa Allergy Immunotherapy Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Allergy Immunotherapy Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Allergy Immunotherapy Market, by Type
      1. By Subcutaneous Immunotherapy (SCIT)
      2. By Sublingual Immunotherapy (SLIT)
    4. Middle East & Africa Allergy Immunotherapy Market, by Allergy Type
      1. By Allergic Rhinitis
      2. By Allergic Asthma
      3. By Food Allergy
      4. By Atopic Dermatitis
      5. By Other Allergy Types
    5. Middle East & Africa Allergy Immunotherapy Market, by Distribution Channel
      1. By Institutional Sales
      2. By Retail Sales
    6. Middle East & Africa Allergy Immunotherapy Market, by Country
      1. GCC Countries
        1. GCC Countries Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. GCC Countries Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. GCC Countries Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      2. South Africa
        1. South Africa Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. South Africa Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. South Africa Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Allergy Immunotherapy Market, By Type
          1. By Subcutaneous Immunotherapy (SCIT)
          2. By Sublingual Immunotherapy (SLIT)
        2. Rest of Middle East & Africa Allergy Immunotherapy Market, By Allergy Type
          1. By Allergic Rhinitis
          2. By Allergic Asthma
          3. By Food Allergy
          4. By Atopic Dermatitis
          5. By Other Allergy Types
        3. Rest of Middle East & Africa Allergy Immunotherapy Market, By Distribution Channel
          1. By Institutional Sales
          2. By Retail Sales
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Merck KGaA (Germany)
    2. Jubilant Pharma (Hollister Allergy) (U.S.)
    3. Leti Pharma (Spain)
    4. Stallergenes Greer (Switzerland)
    5. ALK-Abello A/S (Denmark)
    6. Allergy Therapeutics (UK)
    7. Anergis SA (Switzerland)
    8. ASIT Biotech (Belgium)
    9. DBV Technologies (France)
    10. HAL Allergy Group (Netherlands)
    11. Aimmune Therapeutics (U.S.)
    12. Arrayit Corporation (U.S.)
    13. Biomay AG (Austria)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Allergy Immunotherapy valued at USD 1.63 Billion in 2022 and is expected to reach USD 3.33 Billion in 2030 growing at a CAGR of 9.2%.

  • The prominent players in the market are Merck KGaA (Germany), Jubilant Pharma (Hollister Allergy) (U.S.), Leti Pharma (Spain), Stallergenes Greer (Switzerland), ALK-Abello A/S (Denmark), Allergy Therapeutics (UK), Anergis SA (Switzerland), ASIT Biotech (Belgium), DBV Technologies (France), HAL Allergy Group (Netherlands), Aimmune Therapeutics (U.S.), Arrayit Corporation (U.S.), Biomay AG (Austria).

  • The market is project to grow at a CAGR of 9.2% between 2023 and 2030.

  • The driving factors of the Allergy Immunotherapy include

  • Europe was the leading regional segment of the Allergy Immunotherapy in 2022.